Peter Attia MD247 ‒ Preventing cardiovascular disease: the latest in imaging, blood pressure & metabolic health
At a glance
WHAT IT’S REALLY ABOUT
Cardiologist Ethan Weiss and Peter Attia on Imaging, Blood Pressure, Metabolism
- Weiss and Attia compare calcium scans, which are cheap and low-radiation but imprecise, with CT angiography, which gives much more information but costs more and is hard to get covered.
- Both favor treating anyone with plaque maximally with medical therapy, apoB lowering included, rather than waiting for symptoms, and Weiss argues stenting has little role outside acute MI and refractory symptoms.
- They discuss blood pressure, with Weiss arguing 120 over 80 is normal at any age and citing SPRINT and STEP as support, while acknowledging risks such as falls and kidney effects and the difficulty of measuring a variable number.
- Weiss explains that where fat is stored, particularly a high ratio of visceral to gluteofemoral fat, may drive coronary risk, with lipodystrophy as the extreme example and the focus of his new biotech work.
IDEAS WORTH REMEMBERING
5 ideasA zero calcium score can be misleading, especially at younger ages.
Attia's own score went from six to zero to two for what was essentially the same tiny lesion, and he cites data that about 15% of people with a zero CAC have a finding on CTA.
CTA offers far more information than a calcium scan, but cost and access are barriers.
Weiss says he would go straight to CTA if it were universally covered, but out-of-pocket prices range widely, and radiation can differ about tenfold between scanners.
Treat plaque aggressively and early rather than waiting for severe disease.
Both say that once plaque is present they pull every lever, and Attia likens waiting for a 30% stenosis to waiting for lung damage before telling a smoker to stop.
Stenting has a narrow role outside acute events.
Weiss says stenting is standard in STEMI and urgent for unstable presentations, but trials like COURAGE led him to favor optimal medical therapy for asymptomatic or stable patients, which is why he sees little added value in CT-FFR.
Statins raise calcification yet lower events, which complicates reading a calcium score.
Weiss is comfortable reassuring statin users about higher calcium but not athletes who are statin-naive, saying the burden of proof is on showing that exercise-related calcium is not risky.
WORDS WORTH SAVING
5 quotesI'm treating the causative risks, not the end-stage problems. Like if the goal is I need to wait until you have a 30% stenosis or a calcium score of 200 to start acting, that's insane.
— Peter Attia
ASCVD should basically be an orphan disease. There's actually no reason it needs to be the leading cause of death. It really doesn't even need to be in the top 10. It's that preventable if you start early enough and if you're maximally aggressive.
— Peter Attia
I think it's very easy to convince people to be scared of something. It's a lot harder to make people un-scared of something.
— Ethan Weiss
Blood pressure is one of these funny things. For whatever reason, it's just not sexy, and it's very hard to convince somebody to do something that doesn't make them feel better, and in some cases, may make them feel worse.
— Ethan Weiss
It's not so much even how much fat you have, it's where you carry it.
— Ethan Weiss
High quality AI-generated summary created from speaker-labeled transcript.
